Elaine Chen
Senior Scientist, Translational Biology Rondo Therapeutics
Seminars
Wednesday 16th September 2026
Co-Stimulatory Bispecific Engagers for the Treatment of Solid Tumors
4:45 pm
- Developing a suite of CD28 agonistic antibodies optimized for bispecific engineering to target solid tumors
- Addressing the limited translation of transformative outcomes of T-cell engagers in hematologic cancers, into solid tumors
- Integrating CD28 costimulation into bispecific therapeutics to enhance T-cell effector function and drive robust anti-tumor responses in the solid tumor setting
